24.04.2024 08:09:59 - dpa-AFX: *GSK SAYS US FDA ACCEPTS FOR PRIORITY REVIEW ITS APPLICATION FOR EXPANDED INDICATION OF JEMPERLI

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH